• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4619556)   Today's Articles (4934)   Subscriber (49403)
For: Sun X, Chen C. Comparison of Finkelstein’s Method With the Conventional Approach for Interval-Censored Data Analysis. Stat Biopharm Res 2010. [DOI: 10.1198/sbr.2010.09013] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Number Cited by Other Article(s)
1
Webb A, Ma J. Cox models with time-varying covariates and partly-interval censoring-A maximum penalised likelihood approach. Stat Med 2023;42:815-833. [PMID: 36585040 PMCID: PMC10107645 DOI: 10.1002/sim.9645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2022] [Revised: 09/30/2022] [Accepted: 12/20/2022] [Indexed: 01/01/2023]
2
Beyene KM, El Ghouch A. Time-dependent ROC curve estimation for interval-censored data. Biom J 2022;64:1056-1074. [PMID: 35523738 DOI: 10.1002/bimj.202000382] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2020] [Revised: 10/20/2021] [Accepted: 11/07/2021] [Indexed: 11/10/2022]
3
Mehrotra DV, Zhang Y. Hazard ratio estimation and inference in clinical trials with many tied event times. Stat Med 2018;37:3547-3556. [PMID: 29900572 DOI: 10.1002/sim.7843] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2018] [Revised: 04/13/2018] [Accepted: 05/12/2018] [Indexed: 11/08/2022]
4
Cure rate proportional odds models with spatial frailties for interval-censored data. COMMUNICATIONS FOR STATISTICAL APPLICATIONS AND METHODS 2017. [DOI: 10.29220/csam.2017.24.6.605] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
5
Dugué AE, Pulido M, Chabaud S, Belin L, Gal J. How to Deal with Interval-Censored Data Practically while Assessing the Progression-Free Survival: A Step-by-Step Guide Using SAS and R Software. Clin Cancer Res 2016;22:5629-5635. [PMID: 27663596 DOI: 10.1158/1078-0432.ccr-16-1017] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2016] [Revised: 08/04/2016] [Accepted: 08/12/2016] [Indexed: 11/16/2022]
6
Pan C, Cai B, Wang L, Lin X. Bayesian semiparametric model for spatially correlated interval-censored survival data. Comput Stat Data Anal 2014. [DOI: 10.1016/j.csda.2013.11.016] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
7
Chen DG, Yu L, Peace KE, Lio YL, Wang Y. Approximating the baseline hazard function by taylor series for interval-censored time-to-event data. J Biopharm Stat 2013;23:695-708. [PMID: 23611204 DOI: 10.1080/10543406.2012.756497] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
8
Gong Q, Fang L. Comparison of different parametric proportional hazards models for interval-censored data: A simulation study. Contemp Clin Trials 2013;36:276-83. [DOI: 10.1016/j.cct.2013.07.012] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2013] [Revised: 07/26/2013] [Accepted: 07/28/2013] [Indexed: 11/25/2022]
9
Bushnell W, Stone A. Research outcomes and recommendations for the assessment of progression in cancer clinical trials. J Biopharm Stat 2013;23:949-50. [PMID: 23957508 DOI: 10.1080/10543406.2013.813718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
10
Denne JS, Stone AM, Bailey-Iacona R, Chen TT. Missing Data and Censoring in the Analysis of Progression-Free Survival in Oncology Clinical Trials. J Biopharm Stat 2013;23:951-70. [DOI: 10.1080/10543406.2013.813515] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
11
Sun X, Li X, Chen C, Song Y. A Review of Statistical Issues with Progression-Free Survival as an Interval-Censored Time-to-Event Endpoint. J Biopharm Stat 2013;23:986-1003. [DOI: 10.1080/10543406.2013.813524] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
12
Fay MP, Shih JH. Weighted logrank tests for interval censored data when assessment times depend on treatment. Stat Med 2012;31:3760-72. [PMID: 22786795 DOI: 10.1002/sim.5447] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2011] [Revised: 04/27/2012] [Accepted: 04/30/2012] [Indexed: 11/11/2022]
13
Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group. Eur J Cancer 2011;47:1763-71. [DOI: 10.1016/j.ejca.2011.02.011] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2010] [Accepted: 02/16/2011] [Indexed: 11/20/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA